{"data": [{"news_url": "https://www.zacks.com/stock/news/1061690/4-biotechs-that-have-more-than-doubled-thanks-to-coronavirus", "image_url": "https://cdn.snapi.dev/images/v1/t/6/biotech39.jpg", "title": "4 Biotechs That Have More Than Doubled Thanks to Coronavirus", "text": "Stocks of several small biotech companies more than double so far this year as they taste success in their efforts to make a vaccine/medicine for treating COVID-19.", "source_name": "Zacks Investment Research", "date": "Tue, 22 Sep 2020 10:01:00 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["BNTX", "MRNA", "NVAX", "VIR"]}, {"news_url": "https://www.fool.com/investing/2020/09/22/3-absurdly-overvalued-stocks-to-avoid-during-a-mar/", "image_url": "https://cdn.snapi.dev/images/v1/v/r/urlhttps3a2f2fgfoolcdncom2feditorial2fimages2f5922732fgettyimages-1211369368jpgw700opresize.jpg", "title": "3 Absurdly Overvalued Stocks to Avoid During a Market Crash", "text": "Now is the time to take profits on these three high-flying growth stocks in case of a stock market crash.", "source_name": "The Motley Fool", "date": "Tue, 22 Sep 2020 08:34:00 -0400", "topics": [], "sentiment": "Negative", "type": "Article", "tickers": ["MRNA", "SNOW", "TSLA"]}, {"news_url": "https://investorplace.com/2020/09/mrna-stock-looks-like-a-winner-35-billion-sales-possbile/", "image_url": "https://cdn.snapi.dev/images/v1/b/x/sw22w322.jpg", "title": "Moderna Stock Looks Like a Winner as the Covid-19 Vaccine Race Loosens", "text": "Moderna looks like it has a winner with its Covid-19 vaccine. MRNA stock could make $35 billion if it delivers 1 billion doses, making its $26 billion market cap look cheap.", "source_name": "InvestorPlace", "date": "Tue, 22 Sep 2020 08:10:37 -0400", "topics": [], "sentiment": "Positive", "type": "Article", "tickers": ["MRNA"]}, {"news_url": "https://www.reuters.com/article/us-usa-stocks-vaccine-analysis/covid-19-vaccine-verdicts-loom-as-next-big-market-risk-idUSKCN26D0FW", "image_url": "https://cdn.snapi.dev/images/v1/m/0/m02d20200922t2i1534400652w940fhfwllplsqrlynxnpeg8l097.jpg", "title": "COVID-19 vaccine verdicts loom as next big market risk", "text": "Optimism that vaccines are on the way to end the coronavirus pandemic has been a major factor in this year\u2019s U.S. stock resurgence.", "source_name": "Reuters", "date": "Tue, 22 Sep 2020 01:06:00 -0400", "topics": [], "sentiment": "Neutral", "type": "Article", "tickers": ["MRNA", "PFE"]}]}